Future risk prediction models should integrate stroke-specific variables—such as the NIHSS, infarct location and size, degree of immobility, and inflammatory markers (e.g., IL-6, D-dimer)—with imaging findings to generate more accurate, individualised assessments. This evidence concerns the gene IL6 and stroke disorder.